Cargando…

Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients

BACKGROUND: Lung adenocarcinoma (LUAD) is an extraordinarily malignant tumor, with rapidly increasing morbidity and poor prognosis. Immunotherapy has emerged as a hopeful therapeutic modality for lung adenocarcinoma. Furthermore, a prognostic model (based on immune genes) can fulfill the purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Qianhe, Li, Qifan, Shao, Chenye, Zhang, Pengpeng, Hu, Zhuangzhuang, Li, Jun, Wang, Wei, Yu, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517491/ https://www.ncbi.nlm.nih.gov/pubmed/37741993 http://dx.doi.org/10.1186/s12885-023-11249-8

Ejemplares similares

Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma
por: Gong, Zetian, et al.
Publicado: (2022)

BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration
por: Xu, Linlong, et al.
Publicado: (2021)

BIRC5 Modulates PD-L1 Expression and Immune Infiltration in Lung Adenocarcinoma
por: Ma, Teng, et al.
Publicado: (2022)

Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis
por: Cao, Yajuan, et al.
Publicado: (2019)

Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode
por: Jiawei, Zhou, et al.
Publicado: (2020)

Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
por: Fäldt Beding, Anna, et al.
Publicado: (2022)

A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts
por: Ren, Qianhe, et al.
Publicado: (2023)

Identification of Novel Prognostic Biomarkers Relevant to Immune Infiltration in Lung Adenocarcinoma
por: Xia, Zhi, et al.
Publicado: (2022)

The integrated single-cell analysis developed a lactate metabolism-driven signature to improve outcomes and immunotherapy in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Identification of SHMT2 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Lung Adenocarcinoma
por: Luo, Lianxiang, et al.
Publicado: (2021)

Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis
por: Dai, Jian-bo, et al.
Publicado: (2020)

BIRC3 and BIRC5: multi‐faceted inhibitors in cancer
por: Frazzi, Raffaele
Publicado: (2021)

Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma
por: Ying, Junjie, et al.
Publicado: (2023)

Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5
por: Xu, Rongzhong, et al.
Publicado: (2021)

Identification of fatty acid-related subtypes, the establishment of a prognostic signature, and immune infiltration characteristics in lung adenocarcinoma
por: Wang, Yuzhi, et al.
Publicado: (2023)

Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma
por: Yang, Jian, et al.
Publicado: (2022)

Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma
por: Sun, Ziquan, et al.
Publicado: (2022)

Establishment of the Prognostic Index Reflecting Tumor Immune Microenvironment of Lung Adenocarcinoma Based on Metabolism-Related Genes
por: Zhang, Jianguo, et al.
Publicado: (2020)

Identification of an immune prognostic 11-gene signature for lung adenocarcinoma
por: Yang, Tao, et al.
Publicado: (2021)

NCAPH is a prognostic biomarker and associated with immune infiltrates in lung adenocarcinoma
por: Li, Chao, et al.
Publicado: (2022)

Identification of prognostic genes in lung adenocarcinoma immune microenvironment
por: Han, Lian-Kui, et al.
Publicado: (2021)

BIRC5 Inhibition Is Associated with Pyroptotic Cell Death via Caspase3-GSDME Pathway in Lung Adenocarcinoma Cells
por: Zhang, Qingwei, et al.
Publicado: (2023)

The N6-Methylandenosine-Related Gene BIRC5 as a Prognostic Biomarker Correlated With Cell Migration and Immune Cell Infiltrates in Low Grade Glioma
por: Jiang, Xiulin, et al.
Publicado: (2022)

The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy
por: Zhang, Pengpeng, et al.
Publicado: (2023)

A Novel Prognostic Model of Early-Stage Lung Adenocarcinoma Integrating Methylation and Immune Biomarkers
por: Ren, Jin, et al.
Publicado: (2021)

miR-101-3p sensitizes lung adenocarcinoma cells to irradiation via targeting BIRC5
por: Meng, Xin, et al.
Publicado: (2021)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023)

Identification of a coagulation‐related signature correlated with immune infiltration and their prognostic implications in lung adenocarcinoma
por: Yang, Siqian, et al.
Publicado: (2023)

Long non-coding RNA linc00665 promotes lung adenocarcinoma progression and functions as ceRNA to regulate AKR1B10-ERK signaling by sponging miR-98
por: Cong, Zhuangzhuang, et al.
Publicado: (2019)

Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma
por: Yuan, Yinjiao, et al.
Publicado: (2023)

Identification of Prognostic Immune-Related Genes in Pancreatic Adenocarcinoma and Establishment of a Prognostic Nomogram: A Bioinformatic Study
por: Wu, Guolin, et al.
Publicado: (2020)

GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma
por: Song, Shimao, et al.
Publicado: (2022)

Identification and Validation of Afatinib Potential Drug Resistance Gene BIRC5 in Non-Small Cell Lung Cancer
por: Zhu, Xiaoxi, et al.
Publicado: (2021)

LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
por: Jin, Xin, et al.
Publicado: (2021)

BIRC5/Survivin Expression as a Non-Invasive Biomarker of Endometriosis
por: Filipchiuk, Carolina, et al.
Publicado: (2020)

Identification of memory B-cell-associated miRNA signature to establish a prognostic model in gastric adenocarcinoma
por: Liu, Ruquan, et al.
Publicado: (2023)

GPI Is a Prognostic Biomarker and Correlates With Immune Infiltrates in Lung Adenocarcinoma
por: Han, Jiahui, et al.
Publicado: (2021)

Establishing an 8‐gene immune prognostic model based on TP53 status for lung adenocarcinoma
por: Wu, Guodong, et al.
Publicado: (2022)

TCN1 is a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma
por: Li, Haining, et al.
Publicado: (2022)

Characterizing the Metabolic and Immune Landscape of Non-small Cell Lung Cancer Reveals Prognostic Biomarkers Through Omics Data Integration
por: Wang, Fengjiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_afluhvmltg79hflls29kfg5lve